← Back
Data updated: Mar 10, 2026
SPH ZHONGXI PHARM
Neurology
SPH ZHONGXI PHARM is a generic drug manufacturer focused on Neurology.
2025
Since
2
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ESLICARBAZEPINE ACETATE 2025-11-03
ESLICARBAZEPINE ACETATE 2025-08-04
VALGANCICLOVIR HYDROCHLORIDE 2025-04-16
VALGANCICLOVIR HYDROCHLORIDE 2024-06-11
VALGANCICLOVIR HYDROCHLORIDE 2024-05-23
Labeling
VALGANCICLOVIR HYDROCHLORIDE 2024-05-23
Labeling
ESLICARBAZEPINE ACETATE 2024-03-27
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2025-04-16
- Latest
- 2025-11-03
- Applications
- 2